US Patent Number

10,772,940

Publication Date

9-15-2020

Abstract

The presently-disclosed subject matter includes isolated polypeptides that comprise a butyrylcholinestrase (BChE) polypeptide and a second polypeptide. The BChE polypeptide as well as the second polypeptide can be variants and/or fragments thereof. The presently-disclosed subject matter also includes a pharmaceutical composition that comprises the present isolated polypeptide and a suitable pharmaceutical carrier. Further still, methods are provided for treating cocaine-induced conditions, and comprise administering the isolated polypeptide and/or pharmaceutical compositions thereof to an individual.

Assignees

University of Kentucky Research Foundation, Lexington, KY (US)

Application Number

14/102,977

Filing Date

12-11-2013

Share

COinS